CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-25 | DAVIS STEPHEN CEO | Grant or award · Stock Option (Right to Buy) | +286,451 | 286,451 | ||
| 2024-03-25 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Grant or award | +10,550 | 31,617 | ||
| 2024-03-25 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Grant or award · Stock Options (Right to Buy) | +80,564 | 80,564 | ||
| 2024-03-25 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +24,714 | 24,714 | ||
| 2024-02-26 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sale | −772 | $24.67 | $19K | 21,067 |
| 2024-02-26 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Sale | −624 | $24.67 | $15K | 31,432 |
| 2024-02-26 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Sale | −474 | $24.67 | $12K | 11,391 |
| 2024-02-26 | DAVIS STEPHEN CEO | Sale | −5,577 | $24.67 | $138K | 101,890 |
| 2024-02-23 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise | +1,353 | 21,839 | ||
| 2024-02-23 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −1,353 | 1,353 | ||
| 2024-02-23 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Option exercise | +1,107 | 32,056 | ||
| 2024-02-23 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Option exercise · Restricted Stock Units | −1,107 | 1,107 | ||
| 2024-02-23 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise | +840 | 11,865 | ||
| 2024-02-23 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise · Restricted Stock Units | −840 | 840 | ||
| 2024-02-23 | DAVIS STEPHEN CEO | Option exercise | +10,946 | 107,467 | ||
| 2024-02-23 | DAVIS STEPHEN CEO | Option exercise · Restricted Stock Units | −10,946 | 10,946 | ||
| 2024-02-06 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | Grant or award · Stock Option (Right to Buy) | +126,589 | 126,589 | ||
| 2024-02-06 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | Grant or award · Restricted Stock Units | +25,889 | 25,889 | ||
| 2024-01-08 | DAVIS STEPHEN CEO | Sale | −3,732 | $29.96 | $112K | 96,521 |
| 2024-01-08 | Teehan Brendan EVP, COO, Head of Commercial | Sale | −731 | $29.96 | $22K | 30,949 |
Page 15 of 63 · 1,260 trades